Ryan Ungaro
Icahn School of Medicine at Mount Sinai
H-index: 43
North America-United States
Top articles of Ryan Ungaro
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
P1177 Perceptions of patients with Inflammatory Bowel Disease and first degree relatives on prediction and prevention of disease | Journal of Crohn's and Colitis | A Bravo SG Christensen M Julsgaard IR Lago D Ginard | 2024/1/1 |
DOP68 Natural history of isolated Crohn's Disease perianal fistula | Journal of Crohn's and Colitis | L Sangmo B Quraishi P Rajauria JF Colombel R Ungaro | 2024/1/1 |
Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry | Clinical and translational gastroenterology | Hans H Herfarth Anita Afzali Monika Fischer David Hudesman Maisa Abdalla | 2024/3/1 |
P305 The serum protein profile across the IBD spectrum: Results from the COLLIBRI consortium | Journal of Crohn's and Colitis | B Salomon P Sudhakar B Verstockt RC Ungaro K Aden | 2024/1/1 |
P1143 Per-and poly-fluoroalkyl substances (PFAS) exposure is associated with later occurrence of inflammatory bowel disease | Journal of Crohn's and Colitis | M Agrawal V Midya A Maroli D Valvi J Magee | 2024/1/1 |
DEVELOPMENT OF CROHN'S DISEASE IN PATIENT PRESENTING WITH COMPLEX PERIANAL FISTULA TO A TERTIARY MEDICAL CARE CENTER | Lodoe Sangmo Baseer Quraishi Palak Rajauria Ryan Ungaro Serre-Yu Wong | 2024/2/1 | |
DOP05 Bowel damage and its correlation with the disability index in patients with recently diagnosed Crohn´ s Disease | Journal of Crohn's and Colitis | J Revés G Roager Madsen J Burisch C Wong N Arebi | 2024/1/1 |
P509 Upadacitinib improves symptomatic responses in patients with moderately to severely active Crohn’s disease | Journal of Crohn's and Colitis | I Blumenstein J Torres C Ma JO Lindsay R Ungaro | 2024/1/1 |
Defining Endoscopic Remission in Crohn’s Disease: MM-SES-CD and SES-CD Thresholds Associated with Low Risk of Disease Progression | Clinical Gastroenterology and Hepatology | Neeraj Narula Emily CL Wong Parambir S Dulai Jaiminkumar Patel John K Marshall | 2024/2/28 |
INCREASING ACCESS TO INTERDISCIPLINARY IBD CARE FOR NEWLY DIAGNOSED IBD PATIENTS USING TELEMEDICINE: AN EXTENSION OF THE COMPASS-IBD PROGRAM | Gastroenterology | Ayanna Lewis Mahnoor Khan Chandana Lanka Laura Manning Kristina Matos | 2024/2/1 |
Disability in Crohn’s Disease Patients at diagnosis: Findings from the CROCO (Crohn´ s Disease Cohort) study | Joana Reves Gorm Roager Madsen Johan Burisch Charlotte Wong Naila Arebi | 2024 | |
P226 Disability in Crohn’s Disease Patients at diagnosis: Findings from the CROCO (Crohn´ s Disease Cohort) study | Journal of Crohn's and Colitis | J Revés G Roager Madsen J Burisch C Wong N Arebi | 2024/1/1 |
P420 Natural history of intra-abdominal inflammatory masses (phlegmons) in Crohn’s disease | Journal of Crohn's and Colitis | A Djalal P Sehgal S Shenoy C Benson P Rajauria | 2024/1/1 |
Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium | Inflammatory Bowel Diseases | Andres J Yarur Ryan Ungaro Katherine Huang Wenfei Wang Priya Sasankan | 2024/3/26 |
Long-Term Effectiveness and Durability of COVID-19 Vaccination among Patients with Inflammatory Bowel Disease | Clinical Gastroenterology and Hepatology | Erica J Brenner Kimberly N Weaver Xian Zhang Arthur J Kastl Jennifer A Strople | 2024/2/17 |
P253 Knowledge and acceptability of the Lémann Index to measure progressive intestinal damage in Crohn’s disease: results from an international cross-sectional survey | Journal of Crohn's and Colitis | C Wong J Torres J Burisch RC Ungaro JF Colombel | 2024/1/1 |
Perceptions of patients with Inflammatory Bowel Disease and first degree relatives on prediction and prevention of disease | Inflammatory bowel diseases | Millie D Long R Jean Cadigan Suzanne F Cook Kaaren Haldeman Kriste Kuczynski | 2015/1/1 |
P683 Economic impact of achieving mucosal healing on UC-related hospitalisations and work productivity in patients with moderately to severely active UC: A post-hoc analysis of … | Journal of Crohn's and Colitis | L Peyrin-Biroulet R Ungaro DT Rubin B Bokemeyer E Ricart | 2024/1/1 |
DOP33 Distinct perturbances in metabolic pathways associate with disease progression in patients with Inflammatory Bowel Disease | Journal of Crohn's and Colitis | AR Bourgonje S Ibing C Argmann BE Sands M Dubinsky | 2024/1/1 |
Shorter Crohn’s Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies | Gastro Hep Advances | Laurent Peyrin-Biroulet Jean-Frederic Colombel Edouard Louis Marc Ferrante Satoshi Motoya | 2024/3/7 |
